NEW YORK, NY / ACCESSWIRE / October 29, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Sundial Growers Inc. (NASDAQ:SNDL)
Class Period: pursuant and/or traceable to the registration statement issued in connection with Sundial's August 1, 2019 initial public stock offering.
Lead Plaintiff Deadline: November 25, 2019
During the class period, Sundial Growers Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Sundial failed to supply saleable cannabis in line with contractual obligations to Zenabis Global Inc.; (2) due to material quality issues, Zenabis had to return or reject a total of 554 kg of cannabis to Sundial, valued at approximately U.S. $1.9 million (C$2.5 million); and (3) as a result, defendants' statements about Sundial's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Learn about your recoverable losses in SNDL: http://www.kleinstocklaw.com/pslra-1/sundial-growers-inc-loss-submission-form?id=4088&from=1.
MacroGenics, Inc. (MGNX)
Class Period: February 6, 2019 to June 3, 2019
Lead Plaintiff Deadline: November 12, 2019
Throughout the class period, MacroGenics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had conducted the progression-free survival ("PFS") and first interim overall survival ("OS") analyses for the SOPHIA trial by no later than October 10, 2018; (b) the October 2018 PFS analysis showed a 0.9 month improvement in PFS; and (c) the October 2018 OS interim analysis did not produce a statistically significant result and the interim OS Kaplan-Meier curves crossed in several spots (thereby violating the constant hazard assumption) and separated late.
Learn about your recoverable losses in MGNX: http://www.kleinstocklaw.com/pslra-1/macrogenics-inc-loss-submission-form?id=4088&from=1.
The Chemours Company (CC)
Class Period: February 16, 2017 to August 1, 2019
Lead Plaintiff Deadline: December 9, 2019
The Chemours Company allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Chemours had not appropriately accounted and accrued reserves for its environmental liabilities; (2) the possibility of costs exceeding accrued amounts was greater than the Company had represented to a point that could be material; (3) the Company's policies, standards and procedures were not properly designed to prevent unreasonable risk of harm to people and the environment (4) Chemours' handling, manufacture, use, and disposal of hazardous substances was not in accordance with applicable environmental laws and regulations; and (5) as a result of these misrepresentations, Chemours shares traded at artificially inflated prices.
Learn about your recoverable losses in CC: http://www.kleinstocklaw.com/pslra-1/the-chemours-company-loss-submission-form?id=4088&from=1.
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: The Klein Law Firm
View source version on accesswire.com: